title: Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy.
authors: A A M
authors: AA
authors: van der Veldt
authors: A J M
authors: AJ
authors: van den Eertwegh
authors: K
authors: K
authors: Hoekman
authors: F
authors: F
authors: Barkhof
authors: E
authors: E
authors: Boven
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D003072:Cognition Disorders / Q000139:chemically induced*; D015140:Dementia, Vascular / Q000150:complications*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib